Langerhans cell histiocytosis and hypercalcemia: Clinical response to indomethacin

Journal of Pediatric Hematology/Oncology

Volumn 18, Issue 3, 1996, Pages 318-320

  McLean, Thomas W ^a,c   Pritchard, Jon ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Hypercalcemia; Indomethacin; Langerhans cell histiocytosis (LCH)

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CHLORMETHINE; ETOPOSIDE; FUROSEMIDE; INDOMETACIN; METHYLPREDNISOLONE; MITHRAMYCIN; PHOSPHATE; PROSTAGLANDIN SYNTHASE INHIBITOR; STEROID; VINBLASTINE;

ARTICLE; BONE MARROW BIOPSY; CALCIUM BLOOD LEVEL; CASE REPORT; CHILD; CLINICAL FEATURE; HISTIOCYTOSIS X; HUMAN; HYPERCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIODIAGNOSIS; SKIN ULCER; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

CYCLOOXYGENASE INHIBITORS; FATAL OUTCOME; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; HYPERCALCEMIA; INDOMETHACIN; INFANT; MALE; TIME FACTORS;

EID: 0029893560     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199608000-00019     Document Type: Article

References (16)

1. McKay C, Furman WL. Hypercalcaemia complicating childhood malignancies. Cancer 1993;72:256-60.
2. May V, Glowinski J. Histiocytosis X in adults. Apropos of a case with apparently isolated bone localizations and hypercalcemia, and a fatal course. Rev Rhum Mal Osteoartic 1986;53:167-8.
3. Kelly KM, Beverly PCL, Chu AC, et al. Successful in vivo immunolocalization of Langerhans cell histiocytosis with use of a monoclonal antibody, NA1/34. J Pediatr 1994;125:717-22.
4. Ladisch S, Gadner H, Arico M, et al. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994;23:107-10.
5. Sheehan MP, Atherton DJ, Broadbent V, et al. Topical nitrogen mustard: an effective treatment for cutaneous Langerhans cell histiocytosis. J Pediatr 1991;119:317-21.
6. Mundy GR, Ibbotson KJ, D'Souza SM, et al. The hypercalcemia of cancer: clinical implications and pathogenic mechanisms. N Engl J Med 1984;310:1718-27.
7. Ralston SH. The pathogenesis of humoral hypercalcemia of malignancy. Lancet 1987;ii:1443-6.
8. Tashjian, AH. Prostaglandins, hypercalcemia and cancer. N Engl J Med 1975;293:1317-8.
9. Seyberth HW, Segre GV, Morgan JL, et al. Prostaglandins as mediators of hypercalcaemia associated with certain types of cancer. N Engl J Med 1975;293:1278-83.
10. Gibbs J, Dillon MJ, Lang S, et al. Indomethacin responsive hypercalcaemia associated with a renal sarcoma. Arch Dis Child 1990;65:1168-9.
11. Mitchell CD, Harvey W, Gordon D, et al. Rhabdoid Wilms' tumour and prostaglandin-mediated hypercalcaemia. Eur Paediatr Haematol Oncol 1985;2:153-7.
12. Brereton HD, Halushka PV. Alexander RW, et al. Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma. N Engl J Med 1974;291:83-5.
13. Ito H, Sanada T, Katayama T, et al. Indomethacin-responsive hypercalcemia. N Engl J Med 1975;293:558-9.
14. Gonzalez-Crussi F, Hsueh W, Wiederhold MD. Prostaglandins in histiocytosis-X: PG synthesis by histiocytosis-x cells. Am J Clin Pathol 1980;75:243-53.
15. 2 in culture. J Clin Invest 1986;77:326-9.
16. Ralston SH. Medical management of hypercalcaemia. Br J Clin Pharmacol 1992;34:11-20.